GeneDx Holdings (WGS) Intangibles (2022 - 2026)
GeneDx Holdings' (WGS) quarterly Intangibles came in at $141.4 million in Q2 2026, down 20.0% year-over-year from $176.7 million in Q2 2025, and down 2.5% quarter-over-quarter from $145.0 million in Q1 2026.
Analysis
GeneDx Holdings (WGS) Intangibles (2022 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Intangibles for 5 consecutive years, with $141.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Intangibles fell 20.0% year-over-year to $141.4 million in Q2 2026; TTM through Jun 2026 was $141.4 million, a 20.0% decrease from a year earlier, with the FY2025 full-year figure at $168.5 million, up 6.23% from the prior year.
- Intangibles was $141.4 million for Q2 2026 at GeneDx Holdings, down from $145.0 million in the prior quarter.
- Over five years, Intangibles peaked at $193.7 million in Q2 2022 and troughed at $141.4 million in Q2 2026.
- A 5-year average of $170.4 million and a median of $172.6 million in 2025 frame the typical range for Intangibles.
- Across the five-year window, Intangibles grew 6.69% in 2025 and slipped 20.0% in 2026, its largest moves.
- Over 5 years, Intangibles stood at $186.6 million in 2022, then declined by 7.51% to $172.6 million in 2023, then retreated by 8.12% to $158.6 million in 2024, then increased by 6.23% to $168.5 million in 2025, then fell by 16.1% to $141.4 million in 2026.
- The last three Intangibles figures came in at $141.4 million (Q2 2026), $145.0 million (Q1 2026), and $168.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 360.20 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 1.67 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 3.68 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 25.27 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 312.46 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 270.17 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 884,000.00 |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 141.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.35 Mn |
| Mar 31, 2026 | 144.97 Mn |
| Dec 31, 2025 | 168.48 Mn |
| Sep 30, 2025 | 172.59 Mn |
| Jun 30, 2025 | 176.69 Mn |
| Mar 31, 2025 | 155.09 Mn |
| Dec 31, 2024 | 158.60 Mn |
| Sep 30, 2024 | 162.11 Mn |
| Jun 30, 2024 | 165.61 Mn |
| Mar 31, 2024 | 169.12 Mn |
| Dec 31, 2023 | 172.63 Mn |
| Sep 30, 2023 | 176.13 Mn |
| Jun 30, 2023 | 179.64 Mn |
| Mar 31, 2023 | 183.14 Mn |
| Dec 31, 2022 | 186.65 Mn |
| Sep 30, 2022 | 190.16 Mn |
| Jun 30, 2022 | 193.66 Mn |